@article{e25102643e244f9d9d002839f6133ce0,
title = "2017 version of LI-RADS for CT and MR imaging: An update",
abstract = "The Liver Imaging Reporting and Data System (LI-RADS) is a reporting system created for the standardized interpretation of liver imaging findings in patients who are at risk for hepatocellular carcinoma (HCC). This system was developed with the cooperative and ongoing efforts of an American College of Radiology–supported committee of diagnostic radiologists with expertise in liver imaging and valuable input from hepatobiliary surgeons, hepatologists, hepatopathologists, and interventional radiologists. In this article, the 2017 version of LI-RADS for computed tomography and magnetic resonance imaging is reviewed. Specific topics include the appropriate population for application of LI-RADS; technical recommendations for image optimization, including definitions of dynamic enhancement phases; diagnostic and treatment response categories; definitions of major and ancillary imaging features; criteria for distinguishing definite HCC from a malignancy that might be non-HCC; management options following LI-RADS categorization; and reporting.",
author = "Elsayes, {Khaled M.} and Hooker, {Jonathan C.} and Agrons, {Michelle M.} and Kielar, {Ania Z.} and An Tang and Fowler, {Kathryn J.} and Victoria Chernyak and Bashir, {Mustafa R.} and Yuko Kono and Do, {Richard K.} and Mitchell, {Donald G.} and Aya Kamaya and Hecht, {Elizabeth M.} and Sirlin, {Claude B.}",
note = "Funding Information: the present article: member-in-training of the LI-RADS Steering Committee. Activities not related to the present article: disclosed no relevant relationships. Other activities: disclosed no relevant relationships. A.Z.K. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: research grant from GE Healthcare for liver MR imaging project. Other activities: disclosed no relevant relationships. A.T. Activities related to the present article: member of the LI-RADS Steering Committee. Activities not related to the present article: disclosed no relevant relationships. Other activities: disclosed no relevant relationships. M.R.B. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: grants from Siemens Healthcare, GE Healthcare, NGM Biopharmaceuticals, TaiwanJ Pharmaceuticals, and Madrigal Pharmaceuticals; personal fees from RadMD for consulting. Other activities: disclosed no relevant relationships. C.B.S. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article:research grants from Bayer, Siemens Healthcare, GE Healthcare, Supersonic, and Arterys; laboratory service agreements with Alexion, AstraZeneca, Bioclinica, Bristol-Myers Squibb, Bracco Diagnostics, Celgene, Fibrogen, Galmed, Genentech, Genzyme, Gilead, Icon, Intercept, Isis, Janssen, NuSirt, Perspectum, Pfizer, Profil, Sanofi, Shire, Synageva, Tobira, Takeda, and Virtual Scopics. Other activities: disclosed no relevant relationships. Publisher Copyright: {\textcopyright} RSNA, 2017.",
year = "2017",
month = nov,
day = "1",
doi = "10.1148/rg.2017170098",
language = "English (US)",
volume = "37",
pages = "1994--2017",
journal = "Radiographics",
issn = "0271-5333",
publisher = "Radiological Society of North America Inc.",
number = "7",
}